Carbetocin is an oxytocin agent used to control postpartum hemorrhage and bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction of the uterus.
- Mechanism
- Curator reviewed
Carbetocin binds to oxytocin receptors present on the smooth musculature of the uterus, resulting in rhythmic contractions of the uterus, increased frequency of existing contractions, and increased uterine tone. The oxytocin receptor content of the uterus is very low in the non-pregnant state, and increases during pregnancy, reaching a peak at the time of delivery.
- Primary indication
- Used to control postpartum hemorrhage and bleeding after giving birth.Curator reviewed · 2 structured indications
- Formula / weight
- C45H69N11O12S · 988.161 g/mol (avg)
- First approval
- Canada, 1997
- Code names
- LV-101
- Brand names
Resolves to
NSTRIRCPWQHTIA-DTRKZRJBSA-NSMILES[H][C@]1(NC(=O)[C@H](CC2=CC=C(OC)C=C2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)[C@@H](C)CCWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Carbetocin, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account